Clinical orthopaedics and related research
-
Clin. Orthop. Relat. Res. · Mar 2016
Randomized Controlled Trial Multicenter StudyA Randomized Trial Among Compression Plus Nonsteroidal Antiinflammatory Drugs, Aspiration, and Aspiration With Steroid Injection for Nonseptic Olecranon Bursitis.
Olecranon bursitis might be a minor problem in the outpatient clinic but relatively be common to occur. However, there are few well-designed studies comparing approaches to treatment. ⋯ Level II, therapeutic study.
-
Clin. Orthop. Relat. Res. · Mar 2016
How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?
En bloc resection for treatment of sacral tumors is the approach of choice for patients with resectable tumors who are well enough to undergo surgery, and studies describe patient survival, postoperative complications, and recurrence rates associated with this treatment. However, most of these studies do not provide patient-reported functional outcomes other than binary metrics for bowel and bladder function postresection. ⋯ Level III, therapeutic study.
-
Clin. Orthop. Relat. Res. · Mar 2016
What Are the 30-day Readmission Rates Across Orthopaedic Subspecialties?
The Centers for Medicare & Medicaid Services (CMS) now include hip and knee replacements in the Hospital Readmission Reduction Program. The 30-day readmission rate is an important quality metric; however, the incidence has not yet been defined across the numerous orthopaedic subspecialties. Elucidating the readmission rate for each subspecialty may indicate that certain services are being disincentivized by the CMS reimbursement program. Furthermore, the "planned" and "unplanned" definitions of readmission have not been well examined to determine their clinical relevance and representation of safe patient care. Therefore, reducing the 30-day readmission rate has become a top priority in orthopaedic quality assurance. ⋯ Level III, therapeutic study.
-
Clin. Orthop. Relat. Res. · Mar 2016
Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?
Long-term survival for all patients with osteosarcoma using current aggressive adjuvant chemotherapy and surgical resection is between 60% and 70%. In patients who present with nonmetastatic, high-grade extremity osteosarcoma of bone, limb salvage surgery is favored, when appropriate, over amputation to preserve the limb, because limb salvage may lead to a superior quality of life compared with amputation. However, concern remains that in the attempt to preserve the limb, close or microscopically positive surgical margins may have an adverse effect on event-free survival. ⋯ Level III, therapeutic study.